Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3044% above fair value
$27.20+1.54 (+6.00%)
Close on Nov 18, 2026Market cap $2.03BP/E –Yield –
Schrodinger free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Schrodinger's free cash flow for the twelve months ending Jun 30, 2026 was -$130.27M, down 634.5% year over year. For fiscal 2025 it was $12.46M. The highest annual figure on record is $14.22M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.46M | – |
| FY2024 | Dec 31, 2024 | -$164.68M | – |
| FY2023 | Dec 31, 2023 | -$150.14M | – |
| FY2022 | Dec 31, 2022 | -$127.70M | – |
| FY2021 | Dec 31, 2021 | -$77.84M | -647.4% |
| FY2020 | Dec 31, 2020 | $14.22M | – |
| FY2019 | Dec 31, 2019 | -$27.90M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$34.43M | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.34M | -112.1% |
| Q4 FY2025 | Dec 31, 2025 | -$16.13M | – |
| Q3 FY2025 | Sep 30, 2025 | -$62.36M | – |
| Q2 FY2025 | Jun 30, 2025 | -$52.51M | – |
| Q1 FY2025 | Mar 31, 2025 | $143.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$31.99M | – |
| Q3 FY2024 | Sep 30, 2024 | -$34.60M | – |
| Q2 FY2024 | Jun 30, 2024 | -$54.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$43.37M | – |
| Q4 FY2023 | Dec 31, 2023 | -$39.73M | – |
| Q3 FY2023 | Sep 30, 2023 | -$54.86M | – |
| Q2 FY2023 | Jun 30, 2023 | -$20.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$34.67M | – |
| Q4 FY2022 | Dec 31, 2022 | -$26.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$33.36M | – |
| Q2 FY2022 | Jun 30, 2022 | -$26.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$41.41M | – |
| Q4 FY2021 | Dec 31, 2021 | -$20.70M | -148.4% |
| Q3 FY2021 | Sep 30, 2021 | -$13.42M | – |
| Q2 FY2021 | Jun 30, 2021 | -$32.29M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.43M | – |
| Q4 FY2020 | Dec 31, 2020 | $42.73M | – |
| Q3 FY2020 | Sep 30, 2020 | -$12.36M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.54M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.62M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.42M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.22M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.57M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.69M | – |
See a number that looks wrong?